XTX Topco Ltd raised its stake in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) by 148.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,584 shares of the company’s stock after buying an additional 24,827 shares during the period. XTX Topco Ltd owned about 0.07% of Embecta worth $520,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Norges Bank purchased a new position in Embecta in the fourth quarter valued at about $7,653,000. Jacobs Levy Equity Management Inc. grew its stake in shares of Embecta by 95.3% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 643,230 shares of the company’s stock valued at $8,536,000 after buying an additional 313,951 shares in the last quarter. Vanguard Group Inc. increased its holdings in Embecta by 2.7% in the first quarter. Vanguard Group Inc. now owns 7,213,992 shares of the company’s stock worth $95,730,000 after buying an additional 187,916 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new position in Embecta during the second quarter valued at approximately $1,663,000. Finally, Keeley Teton Advisors LLC lifted its stake in Embecta by 87.2% in the first quarter. Keeley Teton Advisors LLC now owns 255,999 shares of the company’s stock valued at $3,397,000 after acquiring an additional 119,269 shares during the last quarter. 93.83% of the stock is currently owned by hedge funds and other institutional investors.
Embecta Stock Performance
EMBC opened at $15.07 on Wednesday. The company has a market cap of $869.09 million, a PE ratio of 12.45 and a beta of 1.00. The stock has a 50-day moving average of $15.10 and a 200-day moving average of $13.31. Embecta Corp. has a 52-week low of $9.93 and a 52-week high of $19.79.
Embecta Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Tuesday, August 27th were given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 3.98%. The ex-dividend date of this dividend was Tuesday, August 27th. Embecta’s dividend payout ratio is 49.59%.
Analyst Ratings Changes
Separately, Morgan Stanley cut their price target on shares of Embecta from $13.00 to $12.00 and set an “underweight” rating on the stock in a report on Monday, July 15th.
Read Our Latest Analysis on EMBC
Embecta Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Featured Stories
- Five stocks we like better than Embecta
- How to Invest in Biotech Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Market Cap Calculator: How to Calculate Market Cap
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How Investors Can Find the Best Cheap Dividend Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding EMBC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Embecta Corp. (NASDAQ:EMBC – Free Report).
Receive News & Ratings for Embecta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embecta and related companies with MarketBeat.com's FREE daily email newsletter.